EpirubicinDeoxycytidineAntineoplastic Combined Chemotherapy ProtocolsAntibiotics, AntineoplasticAntimetabolites, AntineoplasticFluorouracilDrug Administration ScheduleBreast NeoplasmsCyclophosphamidePaclitaxelTaxoidsPancreatic NeoplasmsCisplatinTreatment OutcomeChemotherapy, AdjuvantInfusions, IntravenousVinblastineRazoxaneDisease-Free SurvivalDoxorubicinBiliary Tract NeoplasmsDeoxycytidine KinaseNeoadjuvant TherapyDose-Response Relationship, DrugNeutropeniaAnthracyclinesSurvival RateAdenocarcinomaGranulocyte Colony-Stimulating FactorMaximum Tolerated DoseNeoplasm MetastasisDrug Resistance, NeoplasmNeoplasm StagingAntineoplastic AgentsLung NeoplasmsAlopeciaCarboplatinLeukopeniaCombined Modality TherapyHematologic DiseasesMethotrexateIfosfamideNauseaSurvival AnalysisProlyl HydroxylasesCarcinoma, Non-Small-Cell LungCell Line, TumorVomitingDrug SynergismStomatitisStomach NeoplasmsEquilibrative Nucleoside Transporter 1Disease ProgressionOrganoplatinum CompoundsReceptor, erbB-2Urinary Bladder NeoplasmsAntineoplastic Agents, PhytogenicEtoposideNaphthacenesCarcinoma, Transitional Cell